VOR BIOPHARMA INC (VOR) Stock Balance Sheet
USA - NASDAQ:VOR - US9290332074 - Common Stock
10.01 USD
+0.26 (+2.67%)
10.2 USD
+0.19 (+1.9%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 190.57M | 81.95M | 31.36M | 57.70M | 119.80M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 9.99M | 9.98M | 105.81M | 172.50M | 87.70M | |||
| Receivables | null | null | null | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 4.36M | 4.58M | 3.63M | 6.70M | 6.90M | |||
| Total Current Assets | 204.93M | 96.51M | 140.80M | 237.00M | 214.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 24.00K | 41.59M | 50.10M | 57.10M | 22.50M | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 420.00K | 4.80M | 7.22M | 5.30M | 5.70M | |||
| Total Non-Current Assets | 444.00K | 46.38M | 57.32M | 62.40M | 28.20M | |||
| TOTAL ASSETS | 205.37M | 142.89M | 198.13M | 299.40M | 242.60M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | null | null | null | null | |||
| Accrued Expenses | 58.10M | 17.11M | 14.71M | 11.20M | 8.20M | |||
| Accounts Payable | 669.00K | 1.50M | 815.00K | 1.80M | 1.50M | |||
| Other Current Liabilities | null | 0 | 50.00K | 200.00K | 400.00K | |||
| Total Current Liabilities | 58.77M | 18.61M | 15.57M | 13.10M | 10.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 1.65B | 27.61M | 31.83M | 35.60M | 16.20M | |||
| Total Non-Current Liabilities | 1.65B | 27.61M | 31.83M | 35.70M | 16.10M | |||
| TOTAL LIABILITIES | 1.71B | 46.23M | 47.40M | 48.80M | 26.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.06B | -456.99M | -340.08M | -222.20M | -130.10M | |||
| Additional Paid In Capital | 557.42M | 553.62M | 490.87M | 473.60M | 346.40M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 13.00K | 13.00K | 7.00K | 0 | 0 | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | null | null | null | null | null | |||
| Shares Outstanding | 6.28M | 6.24M | 3.39M | 3.30M | 1.86M | |||
| Tangible Book Value per Share | -239.6734 | 15.494 | 44.4015 | 3.797 | 5.8145 | |||
| Total Shareholders' Equity | -1.51B | 96.66M | 150.72M | 250.60M | 216.30M | |||
| TOTAL LIABILITIES AND EQUITY | 205.37M | 142.89M | 198.13M | 299.40M | 242.60M | |||
| Statistics | ||||||||
| Current Ratio | 3.49 | 5.19 | 9.04 | 18.09 | 21.02 | |||
| Return On Assets (ROA) | -810.45% | -81.82% | -59.49% | -30.76% | -28.91% | |||
| Return On Equity (ROE) | N/A | -120.95% | -78.20% | -36.75% | -32.42% | |||
All data in USD , ROIC based on taxRate of 0.21